Auro Laboratories Ltd
₹234.70▲ +7.75 (+3.41%)
AUROLAB·BSE·Healthcare
Market Cap
144.34 Cr
PE Ratio
41.39
Volume
837
Day High - Low
236.05 - 222.00
52W High-Low
317.00 - 189.40
₹234.70▲ +7.75 (+3.41%)
Market Cap144.34 Cr
PE Ratio41.39
Volume837
Day High - Low236.05 - 222.00
52W High-Low317.00 - 189.40
Auro Laboratories Ltd (AUROLAB): company summary
The company's business has improved, with annual revenue rising 58.5% and net profit jumping 91.8% year-over-year.
Auro Laboratories Ltd (AUROLAB) is a micro-cap Healthcare company valued at ₹144 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Auro Laboratories Ltd last traded at ₹234.7, up 3.41% on the day.
- Recent developments
- On 2026-06-30, the company reported a net profit of ₹1 crore for the latest quarter, marking a turnaround from a net loss in the same quarter a year earlier. The promoter holding increased by 0.22 percentage points to 52.40% as of 2026-06-30.
- Financial performance
- The company's business has improved, with annual revenue rising 58.5% and net profit jumping 91.8% year-over-year. The latest quarter saw revenue surge 216.6% compared to the same quarter a year earlier, and net profit swung from a loss to a profit.
- Valuation multiples
- The stock trades at 41.4 times earnings, a premium to the Healthcare median of 32.0, 3.46 times book value.
- Things to watch
- The company's revenue has declined over the past three years, with a compound annual growth rate of -16.6%. The stock is 28.4% below its 52-week high, and the return on equity remains low at 7.6%.
- Where it stands
- Auro Laboratories Ltd ended the latest quarter with a net profit of ₹1 crore, reversing a previous loss. The stock is 28.4% below its 52-week high, and the company's revenue growth has slowed significantly over the past five years.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
2.9/10
Poor
Fair Value
Sign in to see
ROE
7.62%
Weak
P/E
41.39x
Expensive
Debt / Equity
1.37
Elevated
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
Day₹222.00
₹236.05
52W₹189.40
₹317.00
DocStoX take
Held back by valuation (0.5).
DocStoX score
Low confidence2.9
/10
Poor
Quality
Solid
ROE 7.6%
Valuation
Expensive
P/E 41.4×
Growth
Flat
Revenue -10.7% 5Y CAGR
Risk
Moderate
D/E 1.37
Momentum
Weak
36% of 52-week range
At a glance
Market Cap
₹144 Cr
52W High / Low
₹317 / ₹189
Dividend Yield
0.00%
Promoter Holding
52.40%
EPS (TTM)
₹5.67
Book Value
₹74.36
Key highlights
- Profitable in all of the last 5 years
- Profit shrinking 13% a year
- Revenue shrinking 11% a year
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Auro Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Auro Laboratories Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare Auro Laboratories Ltd with peers
Related tools & concepts
Value Auro Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing